Nano X Imaging Ltd (NNOX)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $25.22M
Last updated: Nov 17, 2026 at 4:28 PM ET
Nano X Imaging Ltd (NNOX) Statistics
Nano X Imaging (NNOX) has a market cap of $25.22M. It kept -747.20% of revenue as net income over the last 12 months. Its share count is up 9.42% from a year earlier.
Total Valuation
| Market Cap | $25.22M |
|---|---|
| Latest price (Nov 17, 2026) | $0.29 |
Key Dates
The next earnings report is expected on Nov 25, 2026, covering the quarter ending Sep 30, 2026.
| Next Earnings Date | Nov 25, 2026 (expected) |
|---|---|
| Last Earnings Date | Jul 20, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 1.3x and 0.3x. Its year-end P/S ranged from 14.0x to 344.9x from 2021 to 2025.
| P/S Ratio | 1.3x |
|---|---|
| Forward P/S | 1.1x |
| P/B Ratio | 0.3x |
| P/TBV Ratio | 0.3x |
Price Statistics
The stock is down 90.32% over 52 weeks and trades 43.14% below its 50-day average.
| Beta (1Y) | 1.21 |
|---|---|
| 52-Week Change | -90.32% |
| 1-Month Change | -29.88% |
| 3-Month Change | -69.09% |
| 6-Month Change | -83.38% |
| 5-Year Change | -98.54% |
| Total Return (1Y) | -90.32% |
| Total Return (3Y CAGR) | -64.70% |
| Total Return (5Y CAGR) | -56.78% |
| Max Drawdown (1Y) | -94.87% |
| Max Drawdown (3Y) | -98.20% |
| Sharpe Ratio (1Y) | -2.10 |
| Correlation with SPY (1Y) | 0.14 |
| 50-Day Average | $0.51 |
| 200-Day Average | $1.43 |
| 52-Week Range | $0.21 to $4.71 |
| RSI (14 Days) | 36.3 |
| Average Volume (20 Days) | 5.98M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.84x current liabilities.
| Current Ratio | 2.84x |
|---|---|
| Quick Ratio | 2.59x |
Returns and Efficiency
Return on equity is -161.19% over the last 12 months, against a 5-year average of -36.56%.
| Return on Equity (ROE) | -161.19% |
|---|---|
| Return on Assets (ROA) | -128.10% |
| Return on Capital Employed (ROCE) | -130.91% |
| ROE (5Y Average) | -36.56% |
| ROA (5Y Average) | -31.60% |
| ROIC (5Y Average) | -31.41% |
| Asset Turnover | 0.11x |
| Inventory Turnover | 20.56x |
| Receivables Turnover | 7.63x |
| Cash Conversion Cycle | 54 days |
Scores
NNOX has an Altman Z-Score of -10.48, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -10.48 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 2 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue of $15.63M over the last 12 months is up 31.52% from the 12 months before.
| Revenue | $15.63M |
|---|---|
| Revenue Growth (YoY) | +31.52% |
| Gross Profit | -$53.17M |
| Operating Income | -$101.00M |
| Pretax Income | -$118.57M |
| Net Income | -$116.81M |
| EBITDA | -$89.98M |
| EBIT | -$101.42M |
| Reported EPS (TTM) | -$1.31 |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
Shareholder equity funds 79.47% of the $91.19M in total assets.
| Cash and Equivalents | $31.02M |
|---|---|
| Working Capital | $25.27M |
| Shareholder Equity | $72.47M |
| Book Value Per Share | $1.04 |
| Tangible Book Value | $57.99M |
| Tangible Book Per Share | $0.83 |
| Total Assets | $91.19M |
| Total Liabilities | $18.72M |
Balance sheet as of Jun 30, 2026.
Cash Flow
After $5.49M of capital spending, operating cash flow left -$53.28M of free cash flow.
| Operating Cash Flow | -$47.79M |
|---|---|
| Capital Expenditures | $5.49M |
| Free Cash Flow | -$53.28M |
| FCF Per Share | -$0.68 |
| Depreciation and Amortization | $11.44M |
Trailing 12 months through Jun 30, 2026.
Margins
The operating margin is -646.09%.
| Gross Margin | -340.09% |
|---|---|
| Operating Margin | -646.09% |
| Pretax Margin | -758.47% |
| Net Margin | -747.20% |
| EBITDA Margin | -575.56% |
| EBIT Margin | -648.76% |
| FCF Margin | -340.83% |
| Gross Margin (5Y Average) | -90.99% |
Growth
Revenue grew 14.93% a year over 3 years.
| Revenue Growth (3Y CAGR) | +14.93% |
|---|---|
| Book Value Per Share Growth (2Y CAGR) | -21.54% |
| Tangible Book Per Share Growth (2Y CAGR) | -22.78% |
Dividends and Yields
NNOX does not pay a dividend. Its free cash flow yield is -265.02%.
| FCF Yield | -265.02% |
|---|---|
| Shareholder Yield | 0.00% |
Peer Position
Against 11 similar companies, NNOX has the 7th highest P/S.
P/S RatioPeer median 2.2x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +8.41%
| P/S Ratio | 1.3x vs 2.2x median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | +31.52% vs +8.41% median |
Analyst Forecast
Consensus estimates put revenue growth at 78.43% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +78.43% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About NNOX
What is NNOX's market cap?
Nano X Imaging has a market cap of $25.22M.
How many shares of NNOX are outstanding?
Nano X Imaging has 69.93M shares outstanding. The count is up 9.42% from a year earlier.
Does NNOX pay a dividend?
No. Nano X Imaging does not pay a dividend.
NNOX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors